---
product_id: 300378136
title: "The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders (McFarland Health Topics)"
price: "¥10596"
currency: JPY
in_stock: true
reviews_count: 5
url: https://www.desertcart.jp/products/300378136-the-promise-of-low-dose-naltrexone-therapy-potential-benefits-in
store_origin: JP
region: Japan
---

# The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders (McFarland Health Topics)

**Price:** ¥10596
**Availability:** ✅ In Stock

## Quick Answers

- **What is this?** The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders (McFarland Health Topics)
- **How much does it cost?** ¥10596 with free shipping
- **Is it available?** Yes, in stock and ready to ship
- **Where can I buy it?** [www.desertcart.jp](https://www.desertcart.jp/products/300378136-the-promise-of-low-dose-naltrexone-therapy-potential-benefits-in)

## Best For

- Customers looking for quality international products

## Why This Product

- Free international shipping included
- Worldwide delivery with tracking
- 15-day hassle-free returns

## Description

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohns disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinsons disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.

Review: Wonderfully researched - a jewel! - I started taking Low Dose Naltrexone in early 2009 for my Hepatitis C and within months had tremendous results. My lab results showed a drop in my HCV viral load from over 1,500,000 to 47,000 and my liver enzymes had returned to normal for the first time since my diagnosis in 2002. It was at this time that I purchased "The Promise of Low Dose Naltrexone" and read it from cover to cover. It enabled me to have a better understanding on how LDN works, particularly on immune disorders, such as Hepatitis B and C: "In his studies on endogenous opiate, Ian Zagon has found that intermittent blockade of the receptor with low doses of opiate antagonist drugs upregulates production of endogenous opiates. Endogenous opiates such as metenkephalin and beta endorphin regulate homeostasis, immunity, wound healing and cellular removal. However, persistent blockade of the opiate receptor and persistent elevations of endogenous opiates, particularly metenkephalin, contribute to cell growth. Several studies of hepatic encephalopathy, Hepatitis B, and Hepatitis C show that higher levels of metenkephalin in the liver are associated with more severe liver damage, cirrhosis, and the development of hepatic encephalopathy. Persistent blockade stimulates cell growth, including cancerous cell growth, whereas intermittent blockade with LDN has an inhibitory effect and restores homeostasis. Along this line, low dose naltrexone has been shown to offer benefits in hepatic encephalopathy, viral hepatitis, and cholestasis-induced liver injury." Wonderfully researched and easy to understand, this book is a must for every researcher, physician or for anyone who is interested in learning more about LDN and how it can help most disorders.
Review: LDN is the most important break trough since penicilline - If you have an autoimmune disease: get this book, read it and pass it on to your doctor! LDN give many patients their lives back.

## Technical Specifications

| Specification | Value |
|---------------|-------|
| Best Sellers Rank | #20,718 in Health, Fitness & Nutrition #20,967 in Healthy Living & Wellness |
| Customer Reviews | 4.4 out of 5 stars 111 Reviews |

## Images

![The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders (McFarland Health Topics) - Image 1](https://m.media-amazon.com/images/I/61zdjJHqmkL.jpg)

## Customer Reviews

### ⭐⭐⭐⭐⭐ Wonderfully researched - a jewel!
*by C***E on 4 April 2010*

I started taking Low Dose Naltrexone in early 2009 for my Hepatitis C and within months had tremendous results. My lab results showed a drop in my HCV viral load from over 1,500,000 to 47,000 and my liver enzymes had returned to normal for the first time since my diagnosis in 2002. It was at this time that I purchased "The Promise of Low Dose Naltrexone" and read it from cover to cover. It enabled me to have a better understanding on how LDN works, particularly on immune disorders, such as Hepatitis B and C: "In his studies on endogenous opiate, Ian Zagon has found that intermittent blockade of the receptor with low doses of opiate antagonist drugs upregulates production of endogenous opiates. Endogenous opiates such as metenkephalin and beta endorphin regulate homeostasis, immunity, wound healing and cellular removal. However, persistent blockade of the opiate receptor and persistent elevations of endogenous opiates, particularly metenkephalin, contribute to cell growth. Several studies of hepatic encephalopathy, Hepatitis B, and Hepatitis C show that higher levels of metenkephalin in the liver are associated with more severe liver damage, cirrhosis, and the development of hepatic encephalopathy. Persistent blockade stimulates cell growth, including cancerous cell growth, whereas intermittent blockade with LDN has an inhibitory effect and restores homeostasis. Along this line, low dose naltrexone has been shown to offer benefits in hepatic encephalopathy, viral hepatitis, and cholestasis-induced liver injury." Wonderfully researched and easy to understand, this book is a must for every researcher, physician or for anyone who is interested in learning more about LDN and how it can help most disorders.

### ⭐⭐⭐⭐⭐ LDN is the most important break trough since penicilline
*by M***R on 11 February 2013*

If you have an autoimmune disease: get this book, read it and pass it on to your doctor! LDN give many patients their lives back.

### ⭐⭐⭐⭐ LDN therapy reference book -- share it with your doctor
*by J***Z on 29 December 2008*

Elaine Moore and Samantha Wilkinson's (Sammy Jo) book on `Low Dose Naltrexone Therapy' is a much needed book. LDN therapy is an off-label use of an established, FDA approved drug - Naltrexone -- used to help modulate the immune system for autoimmune diseases like MS, Crohn's, and others. However, LDN therapy has also been proven beneficial for cancers by helping to reduce tumor size - in pancreatic cancer for example. The dose of Naltrexone used in LDN therapy is similar to the doses that are used in homeopathic medicines. It's good to have a reference that cites credible professionals describing the safety and efficacy of this therapy. The information about LDN therapy is presented so that the average person (non medical) can understand the history behind LDN therapy, how LDN therapy works, and offer guidelines to help a patient talk to their doctor about the applicability of LDN therapy for their own health issues. I particularly liked how the writers broke chapters into smaller sections with clear, descriptive headings -- really made for easy reading even though some of the information is very technical. There are a number of resources included in the book as well as a glossary and index. Specific conditions are also covered - like `autism' for example. Also, information about clinical trials is included. I especially found Sammy Jo's experience with MS and LDN to be very inspiring. I particularly liked that the writers highlighted that the older theories of autoimmune disease proposed that the immune system was `hyperactive, strong, and easily stimulated'. Whereas new theories accept that the immune system in autoimmune disease is in-fact ` weak and ineffective'. I think this point is important because the confusion between the two theories hinders a lot of possible treatment options / therapies. However, I think a doctor / medical professional will find the book most beneficial. Doctors don't have a lot of time to research --- this book consolidates a lot of the [current and historical] information about LDN therapy -- available on various websites -- into one place. It also includes information from LDN researchers that were interviewed and offers patient guidelines for a doctor considering prescribing LDN for their patient. I thought it was especially helpful that some LDN experienced doctors agreed to have their names published as a reference. These doctors offer phone consultations which will be helpful for not only for patients who cannot find a doctor willing to prescribe, but perhaps for other doctors as well. The writers are very clear to point out that LDN therapy is NOT a cure for autoimmune disease nor cancers...but is to be used as a therapy to stop or slow the progression of disease. They also make the important point that larger, clinical trials are needed to allow LDN therapy to become more main stream and so that the larger medical community will become aware of this therapy. I agree with their assessment that a patient should be monitored by their doctor if they decide to try LDN therapy. I want to thank the writers for creating a reference of information on LDN therapy that I'm sure will be helpful to a lot of people.

## Frequently Bought Together

- The Promise Of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
- The LDN Book: How a Little-Known Generic Drug Low Dose Naltrexone Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More
- The LDN: Low Dose Naltrexone; The Latest Research on; Viral Infections, Long COVID, Mold Toxicity, Longevity, Cancer, Depression and More (Ldn, 3)

---

## Why Shop on Desertcart?

- 🛒 **Trusted by 1.3+ Million Shoppers** — Serving international shoppers since 2016
- 🌍 **Shop Globally** — Access 737+ million products across 21 categories
- 💰 **No Hidden Fees** — All customs, duties, and taxes included in the price
- 🔄 **15-Day Free Returns** — Hassle-free returns (30 days for PRO members)
- 🔒 **Secure Payments** — Trusted payment options with buyer protection
- ⭐ **TrustPilot Rated 4.5/5** — Based on 8,000+ happy customer reviews

**Shop now:** [https://www.desertcart.jp/products/300378136-the-promise-of-low-dose-naltrexone-therapy-potential-benefits-in](https://www.desertcart.jp/products/300378136-the-promise-of-low-dose-naltrexone-therapy-potential-benefits-in)

---

*Product available on Desertcart Japan*
*Store origin: JP*
*Last updated: 2026-10-12*